logo-loader
RNS
Sopheon

Issue of Equity

/**/ h1{margin:0cm;margin-bottom:.0001pt;text-align:center;font-size:16.0pt;font-family:"Cambria","serif";color:black;font-weight:bold;}h2{margin:0cm;margin-bottom:.0001pt;font-size:14.0pt;font-family:"Cambria","serif";color:black;font-weight:bold;font-div:italic;}h3{margin:0cm;margin-bottom:.0001pt;font-size:13.0pt;font-family:"Cambria","serif";color:black;font-weight:bold;}h4{margin:0cm;margin-bottom:.0001pt;text-align:center;font-size:14.0pt;font-family:"Calibri","sans-serif";color:black;font-weight:bold;}h5{margin:0cm;margin-bottom:.0001pt;text-align:justify;font-size:13.0pt;font-family:"Calibri","sans-serif";color:black;font-weight:bold;font-div:italic;}h6{margin:0cm;margin-bottom:.0001pt;text-align:justify;font-size:10.0pt;font-family:"Calibri","sans-serif";color:black;font-weight:bold;}p{margin-right:0cm;margin-left:0cm;font-size:11.0pt;font-family:"Verdana","sans-serif";color:black;}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue } visited{ color: purple } .bc{size:612.1pt 792.1pt;margin:70.9pt 70.9pt 1.0cm 70.9pt;}div.bc{}table.ch{margin-left:-5.4pt;border-collapse:collapse}td.ce{width:237.6pt;padding:0cm 5.4pt 0cm 5.4pt}span.cf{font-size:10.0pt;font-weight:normal}td.cc{width:227.7pt;padding:0cm 5.4pt 0cm 5.4pt}p.ci{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Times New Roman","serif";color:black;text-align: right}span.ca{font-size:13.0pt;font-family:"Times New Roman","serif"}span.bz{font-family:"Times New Roman","serif"}p.cj{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;text-align: center} p.ck{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;font-weight: bold; text-align: center}span.bw{font-size:12.0pt}p.cl{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;text-align:justify}span.bv{font-size:10.0pt}p.cm{margin:0cm;margin-bottom:.0001pt;text-align:justify;font-size:8.0pt;font-family:"Times New Roman","serif";color:black;font-weight: bold}span.bt{font-variant:small-caps}p.cn{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;font-weight: bold}span.br{font-size:10.0pt;font-variant:small-caps}table.co{margin-left:auto;margin-right:auto;margin-left:5.4pt;border-collapse:collapse}tr.bl{height:5.9pt} td.bp{width:202.55pt;padding:0cm 5.4pt 0cm 5.4pt; height:5.9pt}p.cp{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;margin-top:6.0pt;layout-grid-mode:char}td.bn{width:123.95pt;padding:0cm 5.4pt 0cm 5.4pt; height:5.9pt}p.cq{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;margin-top:6.0pt;text-align:justify;layout-grid-mode: char}td.bm{width:98.6pt;padding:0cm 5.4pt 0cm 5.4pt; height:5.9pt}p.cr{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;text-align:justify;layout-grid-mode:char}p.cs{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Courier New";color:black;font-weight: bold; text-align: justify}.be{text-decoration: underline}span.bf{font-size: 10.0pt}p.ct{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Times New Roman","serif";color:black;margin-top:6.0pt} /**/
RNS Number : 0404P
Sopheon PLC
05 February 2019
 

For immediate release

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

Issue of Equity

 

Sopheon plc, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, announces that, following the exercise of options by a former employee, it has issued and allotted 1,700 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 8 February 2019.

 

The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,145,466. The Company does not hold any shares in treasury. Accordingly, the figure of 10,145,466 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information contact:

Barry Mence, Chairman
Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (Corporate Finance)

Alice Lane (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
IOEBIGDDSGGBGCS

Quick facts: Sopheon

Price: £7.82

Market: AIM
Market Cap: £79.44 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Second Price Monitoring Extn

3 weeks, 5 days ago

Price Monitoring Extension

3 weeks, 5 days ago

Second Price Monitoring Extn

3 weeks, 5 days ago

Price Monitoring Extension

3 weeks, 5 days ago

Second Price Monitoring Extn

3 weeks, 5 days ago

Price Monitoring Extension

3 weeks, 5 days ago

Half-year Report

3 weeks, 5 days ago